Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Oct 24;12(10):2613–2628. doi: 10.21037/tcr-23-921

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2023 Translational Cancer Research. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

PMC Copyright notice

Relationship between IPM and other clinical data. (A) Univariate and (B) multivariate regression analyses of the relationship between immunological prognostic models and prognostic value of clinicopathological features. (C) Nomograms predict 1-, 3-, and 5-year OS probabilities in LUAD patients. (D) Time-dependent ROC curve analyses of IPM. (E) Calibration curves of nomogram predictions for 1-, 3-, and 5-year OS in patients with LUAD. *, P<0.05; ***, P<0.001; -, no significance. AUC, area under the curve; CI, confidence interval; IPM, immune prognostic mode; LUAD, lung adenocarcinoma; OS, overall survival; ROC, receiver operating characteristic.